Welcome to NHSBT Research and Development
Research and Development is fundamental to NHSBT, to deliver even safer and more effective treatments for patients in the future.Research across NHSBT now involves 17 Principal Investigators, nearly 200 staff and a total budget of £16 million a year. The main research sites, in collaboration with University partners, are Cambridge, Oxford, London and Bristol, with specialist activity in Birmingham and Liverpool.
Our supporting infrastructure consists of the Clinical Biotechnology Centre (Bristol), which manufactures GMP-grade biologicals for Phase 1 clinical trials, the NHSBT/MRC Clinical Studies Unit (Oxford/Cambridge/London), which supports clinical studies and trials, the Systematic Reviews Initiative (Oxford) and the Statistics and Clinical Audit team (Bristol).
On these pages you can find out about our current NIHR programmes, workpackages and projects, and read our latest Triennial Report which reviews projects from 2009-11.
Overview
Triennial Report 2009-11
NHSBT Documentation
Recent Publications
- A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
- Genetic loci influencing the human red blood cell
NHSBT Websites
- NHS Blood and Transplant
- Organ Donation & Transpl...
- Blood Donation
- Tissue Donation
- Trigger Clinical Trial
Follow Us
